Gilles R. Dagenais

5 ta ish

Laval University

1. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

   Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais +97

   MaqolaOAOchiq kirish20192 iqtibos

   ABIABI:AkademIndex/2026.other.057761

2. Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries

   Salim Yusuf, Sumathy Rangarajan, Koon Teo +37

   MaqolaOAOchiq kirish20142 iqtibos

   ABIABI:AkademIndex/2026.other.197106

3. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

   Salim Yusuf, Eva Lonn, Prem Pais +29

   Maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.295802

4. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study

   Mahshid Dehghan, Andrew Mente, Xiaohe Zhang +87

   Maqola20172 iqtibos

   ABIABI:AkademIndex/2026.other.575150

5. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study

   Gilles R. Dagenais, Darryl P. Leong, Sumathy Rangarajan +29

   MaqolaOAOchiq kirishGlobal Health and EpidemiologyThe Lancet20191 iqtibos

   ABIABI:AkademIndex/2026.other.000026